Predictive Oncology EBITDA Margin 2010-2024 | POAI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Predictive Oncology (POAI) over the last 10 years. The current EBITDA margin for Predictive Oncology as of September 30, 2024 is .
Predictive Oncology EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2024-09-30 |
$0.00B |
$-0.01B |
0.00% |
2024-06-30 |
$0.00B |
$-0.01B |
-1300.00% |
2024-03-31 |
$0.00B |
$-0.01B |
-1400.00% |
2023-12-31 |
$0.00B |
$-0.01B |
-1300.00% |
2023-09-30 |
$0.00B |
$-0.02B |
-2200.00% |
2023-06-30 |
$0.00B |
$-0.02B |
0.00% |
2023-03-31 |
$0.00B |
$-0.02B |
0.00% |
2022-12-31 |
$0.00B |
$-0.02B |
0.00% |
2022-09-30 |
$0.00B |
$-0.02B |
0.00% |
2022-06-30 |
$0.00B |
$-0.02B |
0.00% |
2022-03-31 |
$0.00B |
$-0.02B |
0.00% |
2021-12-31 |
$0.00B |
$-0.02B |
0.00% |
2021-09-30 |
$0.00B |
$-0.02B |
0.00% |
2021-06-30 |
$0.00B |
$-0.02B |
0.00% |
2021-03-31 |
$0.00B |
$-0.02B |
0.00% |
2020-12-31 |
$0.00B |
$-0.02B |
0.00% |
2020-09-30 |
$0.00B |
$-0.01B |
0.00% |
2020-06-30 |
$0.00B |
$-0.01B |
-1100.00% |
2020-03-31 |
$0.00B |
$-0.01B |
-1200.00% |
2019-12-31 |
$0.00B |
$-0.01B |
-1100.00% |
2019-09-30 |
$0.00B |
$-0.01B |
-1100.00% |
2019-06-30 |
$0.00B |
$-0.01B |
0.00% |
2019-03-31 |
$0.00B |
$-0.01B |
0.00% |
2018-12-31 |
$0.00B |
$-0.01B |
0.00% |
2018-09-30 |
$0.00B |
$-0.01B |
0.00% |
2018-06-30 |
$0.00B |
$-0.01B |
0.00% |
2018-03-31 |
$0.00B |
$-0.01B |
0.00% |
2017-12-31 |
$0.00B |
$-0.01B |
0.00% |
2017-09-30 |
$0.00B |
$-0.01B |
0.00% |
2017-06-30 |
$0.00B |
$-0.01B |
0.00% |
2017-03-31 |
$0.00B |
$-0.01B |
0.00% |
2016-12-31 |
$0.00B |
$-0.01B |
0.00% |
2016-09-30 |
$0.00B |
$-0.01B |
0.00% |
2016-06-30 |
$0.00B |
$-0.01B |
0.00% |
2016-03-31 |
$0.00B |
$-0.01B |
0.00% |
2015-12-31 |
$0.00B |
$0.00B |
0.00% |
2015-09-30 |
$0.00B |
$0.00B |
0.00% |
2015-06-30 |
$0.00B |
$0.00B |
0.00% |
2015-03-31 |
$0.00B |
$-0.01B |
0.00% |
2014-12-31 |
$0.00B |
$-0.01B |
0.00% |
2014-09-30 |
$0.00B |
$-0.01B |
0.00% |
2014-06-30 |
$0.00B |
$-0.01B |
0.00% |
2014-03-31 |
$0.00B |
$-0.01B |
0.00% |
2013-12-31 |
$0.00B |
$-0.01B |
0.00% |
2013-09-30 |
$0.00B |
$-0.01B |
0.00% |
2013-06-30 |
$0.00B |
$-0.01B |
0.00% |
2013-03-31 |
$0.00B |
$-0.01B |
0.00% |
2012-12-31 |
$0.00B |
$-0.01B |
0.00% |
2012-09-30 |
$0.00B |
$-0.01B |
0.00% |
2012-06-30 |
$0.00B |
$-0.01B |
0.00% |
2012-03-31 |
$0.00B |
$-0.01B |
0.00% |
2010-03-31 |
$0.00B |
$0.00B |
0.00% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Information Systems |
$0.010B |
$0.002B |
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
|